United States · FDA National Drug Code directory
Linezolid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-352_3f14a4cd-195e-41e9-b865-be2e4dff260b
- Product NDC
- 33342-352
- Form
- TABLET, COATED
- Composition / generic term
- Linezolid
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241010
- Source listing expiry
- 20271231
Source-listed ingredients
- LINEZOLID — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (33342-352-06) / 10 TABLET, COATED in 1 BLISTER PACK (33342-352-66) · 33342-352-06
- 100 TABLET, COATED in 1 BOTTLE (33342-352-11) · 33342-352-11
- 5 BLISTER PACK in 1 CARTON (33342-352-31) / 10 TABLET, COATED in 1 BLISTER PACK (33342-352-66) · 33342-352-31
- 20 TABLET, COATED in 1 BOTTLE (33342-352-32) · 33342-352-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →